Free Trial
CVE:IBT

IBEX Technologies (IBT) Stock Price, News & Analysis

C$1.44 0.00 (0.00%)
(As of 04/5/2024)

About IBEX Technologies Stock (CVE:IBT)

Key Stats

Today's Range
C$1.44
C$1.44
50-Day Range
C$1.44
C$1.44
52-Week Range
C$0.75
C$1.45
Volume
200 shs
Average Volume
68,888 shs
Market Capitalization
C$35.29 million
P/E Ratio
9.60
Dividend Yield
3.11%
Price Target
N/A
Consensus Rating
N/A

Company Overview

IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, Germany, the United Kingdom, and internationally. It offers a portfolio of recombinant glycosaminoglycan lyases, including Heparinase I, Heparinase II, Heparinase III, Chondroitinase AC, and Chondroitinase B; collagen ELISAs for the study of synthesis and degradation of connective tissue components; collagen antibodies; and diamine oxidase liquid. The company also manufactures and markets a range of arthritis assays, which are used in osteoarthritis research. In addition, it provides lyophilization services for making disposable medical device components; and custom fermentation and contract manufacturing services. It serves manufacturers of medical devices, quality control labs, low molecular weight heparin manufacturers, and academic research institutions. IBEX Technologies Inc. was incorporated in 1972 and is based in Montreal, Canada.

Receive IBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IBEX Technologies and its competitors with MarketBeat's FREE daily newsletter.

IBT Stock News Headlines

Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
ibex Launches Wave iX Translate
IBEX Completes Sale of the Company
IBEX Technologies Inc.
See More Headlines

IBT Stock Analysis - Frequently Asked Questions

IBEX Technologies' stock was trading at C$1.19 on January 1st, 2024. Since then, IBT shares have increased by 21.0% and is now trading at C$1.44.
View the best growth stocks for 2024 here
.

Shares of IBT stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that IBEX Technologies investors own include Aurora Cannabis (ACB), Acerus Pharmaceuticals (TRLPF), Air Canada (AC), American Airlines Group (AAL), Cognex (CGNX), Baytex Energy (BTE) and Bank of Montreal (BMO).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
C$3.98 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$8 million
Cash Flow
C$0.92 per share
Book Value
C$0.58 per share

Miscellaneous

Free Float
N/A
Market Cap
C$35.29 million
Optionable
Not Optionable
Beta
-0.05
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (CVE:IBT) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners